Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) journalArticle 2015 Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C.
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial journalArticle 2015 Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M.
Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases journalArticle 2019 Mariani, A.; Gelli, M.; Sourrouille, I.; Benhaim, L.; Faron, M.; Honore, C.; Elias, D.; Goere, D.
[Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database] journalArticle 2016 Freyer, G.; Scotte, F.; Borget, I.; Bruyas, A.; Vainchtock, A.; Chouaid, C.
Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time? journalArticle 2017 Bossi, A.; Mottet, N.; Blanchard, P.
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies journalArticle 2015 Sze, H.; Blanchard, P.; Ng, W. T.; Pignon, J. P.; Lee, A. W.
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30 journalArticle 2016 Blanchard, P.; Briganti, A.; Bossi, A.
Long-term outcome of liver transplantation in childhood: A study of 20-year survivors journalArticle 2018 Martinelli, J.; Habes, D.; Majed, L.; Guettier, C.; Gonzalès, E.; Linglart, A.; Larue, C.; Furlan, V.; Pariente, D.; Baujard, C.; Branchereau, S.; Gauthier, F.; Jacquemin, E.; Bernard, O.
Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Breuskin, I.; Temam, S.; Tao, Y.; Janot, F.
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab journalArticle 2016 Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S.
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up journalArticle 2015 Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Statistical approaches for evaluating body composition markers in clinical cancer research journalArticle 2017 Bayar, M. A.; Antoun, S.; Lanoy, E.
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial journalArticle 2018 Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D.
Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow journalArticle 2017 Blanchard, P.; Menard, C.; Frank, S. J.
Dead space closure with quilting suture versus conventional closure with drainage for the prevention of seroma after mastectomy for breast cancer (QUISERMAS): protocol for a multicentre randomised controlled trial journalArticle 2016 Ouldamer, L.; Bonastre, J.; Brunet-Houdard, S.; Body, G.; Giraudeau, B.; Caille, A.
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma journalArticle 2015 Squifflet, P.; Michiels, S.; Siegel, D.; Vij, R.; Jagannath, S.; Saad, E. D.; Rajangam, K.; Ro, S. K.; Buyse, M.
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] journalArticle 2019 Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F.
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients journalArticle 2016 Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F.
[Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?] journalArticle 2018 Margier, J.; Baffert, S.; Le Corroller-Soriano, A. G.
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study journalArticle 2017 Angevin, E.; Cassier, P. A.; Italiano, A.; Goncalves, A.; Gazzah, A.; Terret, C.; Toulmonde, M.; Gravis, G.; Varga, A.; Parlavecchio, C.; Paci, A.; Poinsignon, V.; Soria, J. C.; Drubay, D.; Hollebecque, A.
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al journalArticle 2015 Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M.
Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma journalArticle 2019 Limkin, E. J.; Blanchard, P.
Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group journalArticle 2016 Foulon, S.; Brennan, B.; Gaspar, N.; Dirksen, U.; Jeys, L.; Cassoni, A.; Claude, L.; Seddon, B.; Marec-Berard, P.; Whelan, J.; Paulussen, M.; Streitbuerger, A.; Oberlin, O.; Juergens, H.; Grimer, R.; Le Deley, M. C.
Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials journalArticle 2018 Pistilli, B.; Mazouni, C.; Zingarello, A.; Faron, M.; Saghatchian, M.; Grynberg, M.; Spielmann, M.; Kerbrat, P.; Roche, H.; Lorgis, V.; Bachelot, T.; Campone, M.; Levy, C.; Goncalves, A.; Lesur, A.; Veyret, C.; Vanlemmens, L.; Lemonnier, J.; Delaloge, S.
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients journalArticle 2017 Boros, A.; Lacroix, L.; Lacas, B.; Adam, J.; Pignon, J. P.; Caramella, C.; Planchard, D.; de Montpreville, V.; Deutsch, E.; Levy, A.; Besse, B.; Le Pechoux, C.
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement journalArticle 2015 Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development
New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study journalArticle 2016 Bayar, M. A.; Le Teuff, G.; Michiels, S.; Sargent, D. J.; Le Deley, M. C.
Biomarker Discovery and Validation: Statistical Considerations journalArticle 2021 Fang-Shu Ou, PhD,a, Stefan Michiels, PhD,b Yu Shyr, PhD,c Alex A. Adjei, MD, PhD,d Ann L. Oberg, PhD
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration journalArticle 2015 Gaspar, N.; Hawkins, D. S.; Dirksen, U.; Lewis, I. J.; Ferrari, S.; Le Deley, M. C.; Kovar, H.; Grimer, R.; Whelan, J.; Claude, L.; Delattre, O.; Paulussen, M.; Picci, P.; Sundby Hall, K.; van den Berg, H.; Ladenstein, R.; Michon, J.; Hjorth, L.; Judson, I.; Luksch, R.; Bernstein, M. L.; Marec-Bérard, P.; Brennan, B.; Craft, A. W.; Womer, R. B.; Juergens, H.; Oberlin, O.
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer journalArticle 2016 Lamartina, L.; Ippolito, S.; Danis, M.; Bidault, F.; Borget, I.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Blanchard, P.; Terroir, M.; Deandreis, D.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium journalArticle 2017 Bautista, F.; Moreno, L.; Marshall, L.; Pearson, A. D. J.; Geoerger, B.; Paoletti, X.
Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study journalArticle 2018 Aubrun, F.; Zahr, N.; Langeron, O.; Boccheciampe, N.; Cozic, N.; Belin, L.; Hulot, J. S.; Khiami, F.; Riou, B.
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer journalArticle 2016 Brambilla, E.; Le Teuff, G.; Marguet, S.; Lantuejoul, S.; Dunant, A.; Graziano, S.; Pirker, R.; Douillard, J. Y.; Le Chevalier, T.; Filipits, M.; Rosell, R.; Kratzke, R.; Popper, H.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Tsao, M. S.
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis journalArticle 2016 De Ruysscher, D.; Lueza, B.; Le Pechoux, C.; Johnson, D. H.; O'Brien, M.; Murray, N.; Spiro, S.; Wang, X.; Takada, M.; Lebeau, B.; Blackstock, W.; Skarlos, D.; Baas, P.; Choy, H.; Price, A.; Seymour, L.; Arriagada, R.; Pignon, J. P.; Group, Rtt-Sclc Collaborative
Comparative analysis of durable responders on immune checkpoint inhibitors (ICI) versus other systemic therapies: A meta-analysis of phase III trials journalArticle 2018 Pons-Tostivint, Elvire; Latouche, Aurélien; Vaflard, Pauline; Ricci, Francesco; Loirat, Delphine; Sablin, Marie-Paule; Rouzier, Roman; Kamal, Maud; Morel, Claire; Lecerf, Charlotte; Servois, Vincent; Paoletti, Xavier; Le Tourneau, Christophe
Mining the coding and non-coding genome for cancer drivers journalArticle 2015 Li, J.; Drubay, D.; Michiels, S.; Gautheret, D.
MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity journalArticle 2016 Petit, C.; Dumas, I.; Chargari, C.; Martinetti, F.; Maroun, P.; Doyeux, K.; Tailleur, A.; Haie-Meder, C.; Mazeron, R.
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data journalArticle 2017 Yin, Jun; Paoletti, Xavier; Sargent, Daniel J; Mandrekar, Sumithra J
Single-use flexible bronchoscopes compared with reusable bronchoscopes: Positive organizational impact but a costly solution journalArticle 2018 Châteauvieux, C.; Farah, L.; Guérot, E.; Wermert, D.; Pineau, J.; Prognon, P.; Borget, I.; Martelli, N.